- Portal Hub - Natera
Visit the appropriate Natera™ portal to check on results, schedule conversations with genetic counselors, place orders, or make payments
- Natera - Wikipedia
Natera, Inc is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health
- Natera buys Foresight Diagnostics in $450M cancer testing deal
Natera is looking to grow its portfolio of tools to detect the recurrence of cancer with a deal to acquire Foresight Diagnostics, the Stanford University spinout and developer of blood tests for
- Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer
Atlanta: American Cancer Society, Inc 2024 About Natera Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health
- Natera: A global leader in cell-free DNA testing
Natera advances molecular diagnostics with integrity and scientific rigor, and supports integration of information provided by our tests into health care decision making
- Natera acquires Foresight Diagnostics for up to $450M
Natera last week said it completed the acquisition of Foresight Diagnostics, expanding the company’s position in solid tumor molecular residual disease detection, particularly in lymphoma, a cancer of the lymphatic system The all-stock transaction was valued at $275 million upfront, plus up to $
- Natera Acquires Foresight Diagnostics | Contract Pharma
Natera Inc , a cell-free DNA and precision medicine company, has acquired Foresight Diagnostics, a leader in ultrasensitive molecular residual disease (MRD) detection
- About Us | Natera
Natera's mission is to change the management of disease worldwide by using information gained from a simple blood draw to proactively inform treatment by using cell-free DNA (cfDNA) testing
|